Product Information - Alkermes Medical Affairs

Please select a product

ARISTADA^®

(aripiprazole lauroxil)

ARISTADA INITIO^®

(aripiprazole lauroxil)

Product Information

LYBALVI^®

(olanzapine and samidorphan)

Product Information

VIVITROL^®

(naltrexone for extended-release injectable suspension)

Product Information

LUMRYZ^®

(sodium oxybate for extended-release oral suspension)

Product Information

ALKERMES^® and VIVITROL^® are registered trademarks of Alkermes, Inc. ARISTADA^®, ARISTADA INITIO^®, and LYBALVI^® are registered trademarks of Alkermes Pharma Ireland Limited, used by Alkermes, Inc., under license. LUMRYZ^® is a registered trademark of Flamel Ireland Limited, an affiliate of Alkermes plc.

Connect with Alkermes Medical Affairs

Inquiry*

Name*

Email*

Phone

City, State*

Institution

Credentials

Select contact preferences:

Phone

This form is for U.S. healthcare professionals only. Alkermes collects and uses the personal information you provide to address your MSL request. For information on how we handle your information, please review our privacy policy. Please do not use this form to share any patient information. By providing your information and clicking the button, you indicate that you agree to these terms and conditions.

To report suspected adverse reactions, please contact Alkermes at 1-888-235-8008 or FDA at 1-800-FDA-1088 or http://www.fda.gov/medwatch.